30 Years of Pharma: Perspective in Numbers
Top 10 Generics Companies:
% Generics vs. Brands Globally
Growth in Generics Sales Generics % Growth By Sales
Generic Vs. Non-Generic Use Blockbuster Drugs†
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.